Is a female of Indonesian and Chinese descent at a greater risk for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

H. pylori Risk in Indonesian and Chinese Descent Females

Yes, a female of Indonesian and Chinese descent is at greater risk for H. pylori infection compared to Western populations, with prevalence rates in developing Asian countries reaching 70-90% of the population. 1, 2

Geographic and Ethnic Risk Factors

The risk for H. pylori infection is substantially elevated in individuals of Asian descent, particularly those from Indonesia and China:

  • Developing Asian countries demonstrate H. pylori prevalence of 70-90%, compared to lower rates in developed Western nations 1
  • Chinese populations specifically have been identified as having different gastric cancer risk profiles, with studies noting that indigenous Chinese populations may have elevated gastric cancer risk associated with H. pylori 3
  • Asian ethnicity is recognized as a risk factor for gastric cancer independent of documented gastric intestinal metaplasia (GIM), and this should be considered in clinical decision-making 3

Clinical Implications for Gastric Cancer Risk

The elevated H. pylori prevalence translates to meaningful downstream cancer risk:

  • The NCCN guidelines specifically recommend stronger consideration for EGD surveillance in Lynch syndrome patients of Asian descent, reflecting the recognized elevated gastric cancer risk in Asian populations 4
  • Within Asia-Pacific regions, geographic variation in gastric cancer risk ranges from 2-4% in Western populations to 30% in Korean populations 4
  • H. pylori eradication reduces incident gastric cancer risk by 32% (RR 0.68; 95% CI 0.48-0.96) and gastric cancer mortality by 33% (RR 0.67; 95% CI 0.38-1.17) 3

Transmission and Environmental Factors

The higher prevalence in Indonesian and Chinese populations relates to specific transmission patterns:

  • Person-to-person transmission occurs through oral-oral routes (vomitus, saliva) or fecal-oral routes, with higher incidence in crowded living conditions and poor sanitation 1
  • Waterborne transmission from fecal contamination is particularly important in regions with untreated water, common in developing countries 1
  • Low socioeconomic status, inadequate sanitation, and crowded living conditions facilitate transmission among family members 1, 2
  • Food prepared under suboptimal conditions or exposed to contaminated water increases infection risk 1

Practical Recommendations

For this patient population, active screening for H. pylori should be strongly considered, particularly if she has:

  • Family history of gastric cancer (4.5-fold increased risk) 3
  • Immigration status from high-prevalence regions (infection status remains high in immigrants from countries with high H. pylori prevalence) 2
  • Plans for or existing gastric intestinal metaplasia, where H. pylori eradication is specifically recommended 3

Testing should utilize validated serological tests or non-invasive methods such as urea breath test or stool antigen detection 3, 2, 5

If H. pylori is detected, eradication therapy should be pursued given the established reduction in gastric cancer risk, with confirmation of eradication recommended due to high treatment failure rates 3

Important Caveats

  • Asian Americans have the highest prevalence of CYP2C19 poor metabolizer genotypes, which may affect PPI-based eradication therapy efficacy 3
  • Smoking nearly doubles the risk of persistent H. pylori infection following therapy (OR 1.95; 95% CI 1.55-2.45), so smoking cessation should be addressed 3
  • The combination of H. pylori infection and atrophic gastritis determined by serological examination identifies subjects at particularly high risk for gastric cancer 3

References

Research

Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection.

Advances in experimental medicine and biology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

EGD Surveillance in Lynch Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Helicobacter pylori.

Clinical microbiology reviews, 1997

Related Questions

What is the diagnostic and treatment approach for a patient with suspected Helicobacter (H.) pylori infection, presenting with symptoms such as abdominal pain, bloating, or nausea, and no prior diagnosis or treatment for H. pylori infection?
What is the name of the stool test for diagnosing Helicobacter (H.) pylori infection?
At what hour can H. pylori (Helicobacter pylori) test results be read through endoscopy?
Do I need to test a patient's relatives for Helicobacter pylori (H. Pylori) infection after it was found in the patient?
Do I need to test my entire household for Helicobacter pylori (H. Pylori) if one family member is infected?
Will a patient who is hot and sweating in a cold room be at risk of catching a cold if they remove their excess clothing?
What is the anatomy of the joint causing my knee pain, specifically related to my age and activity level?
Why is it necessary to test for both Hepatitis B surface antigen (HBsAg) and Hepatitis B core antibody (AntiHBc) before starting direct-acting antiviral (DAA) therapy in patients with confirmed Hepatitis C virus (HCV) infection, rather than testing for HBsAg alone?
Can sitting directly in front of an air conditioner (AC) while hot cause health risks, especially for individuals with respiratory issues such as asthma or chronic obstructive pulmonary disease (COPD)?
What are the specificity and sensitivity results of endoscopy in diagnosing gastrointestinal disorders?
Can drinking cold water exacerbate symptoms in a patient with respiratory conditions such as asthma (Asthma) or Chronic Obstructive Pulmonary Disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.